DEEPWAVE PERCUTANEOUS NEUROMODULATION PAIN THERAPY SYSTEM

Stimulator, Nerve, Electrical, Percutaneous (pens), For Pain Relief

BIOWAVE CORPORATION

The following data is part of a premarket notification filed by Biowave Corporation with the FDA for Deepwave Percutaneous Neuromodulation Pain Therapy System.

Pre-market Notification Details

Device IDK061166
510k NumberK061166
Device Name:DEEPWAVE PERCUTANEOUS NEUROMODULATION PAIN THERAPY SYSTEM
ClassificationStimulator, Nerve, Electrical, Percutaneous (pens), For Pain Relief
Applicant BIOWAVE CORPORATION 49 PLAIN STREET North Attleboro,  MA  02760
ContactMary Mcnamara-cullinane
CorrespondentMary Mcnamara-cullinane
BIOWAVE CORPORATION 49 PLAIN STREET North Attleboro,  MA  02760
Product CodeNHI  
CFR Regulation Number882.5890 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2006-04-27
Decision Date2006-08-15
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00859911006065 K061166 000
10859911006024 K061166 000
20859911006007 K061166 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.